Mulmit

TuHURA Biosciences, Inc./NVTuHURA Biosciences, Inc./NV

HURA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-31,000,000-0.63
2024-12-310-23,000,000-1.21
2023-12-310-15,000,000-2.47
2012-06-300-18,885-18,885
2011-06-300-33,136-33,136

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-05-28Bianco James A.Chief Executive Officer150,000
2026-02-12Tendler Craig156,240
2026-02-12Ng George K156,240
2026-02-12MANUSO JAMES S J156,240
2026-02-12List Alan156,240
2026-02-12Hoffman Robert E.156,240
2026-01-06Dearborn DanChief Financial Officer273,696
2026-01-06Bianco James A.Chief Executive Officer610,332
2025-12-12Dearborn DanChief Financial Officer1,531,367
2025-12-12Bianco James A.Chief Executive Officer3,414,891
2025-03-10Tendler Craig151,883
2025-01-02Hoffman Robert E.51,275

8-K events

FiledItems
2026-08-21Creation of a direct financial obligation · Financial statements and exhibits
2026-08-19Unregistered sales of equity securities · Submission of matters to a vote · Financial statements and exhibits
2026-08-14Results of operations · Financial statements and exhibits
2026-08-13Creation of a direct financial obligation · Financial statements and exhibits
2026-07-29Creation of a direct financial obligation · Financial statements and exhibits
2026-07-07Creation of a direct financial obligation · Financial statements and exhibits
2026-06-17Shareholder director nominations
2026-05-29Creation of a direct financial obligation · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…